NovoCure (NVCR) Assets Average (2015 - 2026)

NovoCure (NVCR) has reported Assets Average for 12 consecutive years, with $791.6 million the latest figure, recorded in Q2 2026.

• Quarterly Assets Average fell 36.54% year-over-year to $791.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $791.6 million (down 36.54% YoY) and the FY2025 annual result came in at $1.0 billion, down 14.32% from the prior year.
• Assets Average slipped to $791.6 million in Q2 2026 per NVCR's latest filing, from $796.1 million in the prior quarter.
• Over the last five years, Assets Average for NVCR reached as high as $1.3 billion in Q3 2025 and fell as low as $791.6 million in Q2 2026.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2025 — Assets Average climbed 9.79% — and 2026, when it plunged 36.54%.
• Year by year, Assets Average stood at $1.2 billion in 2022, then declined by 3.1% to $1.1 billion in 2023, then climbed by 7.43% to $1.2 billion in 2024, then declined by 12.07% to $1.1 billion in 2025, then declined by 26.89% to $791.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $791.6 million, $796.1 million, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.